N-of-1 Clinical Trials in Nutritional Interventions Directed at Improving Cognitive Function

Longer life expectancy has led to an increase in the prevalence of age-related cognitive decline and dementia worldwide. Due to the current lack of effective treatment for these conditions, preventive strategies represent a research priority. A large body of evidence suggests that nutrition is invol...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in nutrition (Lausanne) Vol. 6; p. 110
Main Authors Soldevila-Domenech, Natalia, Boronat, Anna, Langohr, Klaus, de la Torre, Rafael
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers 23.07.2019
Frontiers Media S.A
Subjects
Online AccessGet full text
ISSN2296-861X
2296-861X
DOI10.3389/fnut.2019.00110

Cover

More Information
Summary:Longer life expectancy has led to an increase in the prevalence of age-related cognitive decline and dementia worldwide. Due to the current lack of effective treatment for these conditions, preventive strategies represent a research priority. A large body of evidence suggests that nutrition is involved in the pathogenesis of age-related cognitive decline, but also that it may play a critical role in slowing down its progression. At a population level, healthy dietary patterns interventions, such as the Mediterranean and the MIND diets, have been associated with improved cognitive performance and a decreased risk of neurodegenerative disease development. In the era of evidence-based medicine and patient-centered healthcare, personalized nutritional recommendations would offer a considerable opportunity in preventing cognitive decline progression. N-of-1 clinical trials have emerged as a fundamental design in evidence-based medicine. They consider each individual as the only unit of observation and intervention. The aggregation of series of N-of-1 clinical trials also enables population-level conclusions. This review provides a general view of the current scientific evidence regarding nutrition and cognitive decline, and critically states its limitations when translating results into the clinical practice. Furthermore, we suggest methodological strategies to develop N-of-1 clinical trials focused on nutrition and cognition in an older population. Finally, we evaluate the potential challenges that researchers may face when performing studies in precision nutrition and cognition.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Edited by: Yuanlong Pan, Nestlé R&D, United States
Reviewed by: Esther Aarts, Radboud University Nijmegen, Netherlands; James William Simpkins, West Virginia University School of Medicine, United States; Jiong Shi, Barrow Neurological Institute (BNI), United States
This article was submitted to Neuroenergetics, Nutrition and Brain Health, a section of the journal Frontiers in Nutrition
ISSN:2296-861X
2296-861X
DOI:10.3389/fnut.2019.00110